BRIEF published on 11/15/2024 at 15:23, 7 days 11 hours ago The Vanguard Group Discloses Stake in Hargreaves Lansdown Takeover Code Securities Disclosure Vanguard Group Stakeholding Hargreaves Lansdown
BRIEF published on 11/15/2024 at 15:20, 7 days 11 hours ago The Vanguard Group Discloses Position in Centamin plc Takeover Code Securities Disclosure Vanguard Group AngloGold Ashanti Centamin Plc
PRESS RELEASE published on 11/15/2024 at 15:18, 7 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses a 3.95% interest in Hargreaves Lansdown plc's 0.4p ordinary shares on 14 Nov 2024 Disclosure Vanguard Group Hargreaves Lansdown Plc 0.4p Ordinary Shares
BRIEF published on 11/15/2024 at 15:16, 7 days 11 hours ago The Vanguard Group Discloses Stake in AngloGold Ashanti Takeover Code Securities Disclosure Vanguard Group AngloGold Ashanti Stakeholding
PRESS RELEASE published on 11/15/2024 at 15:15, 7 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc The Vanguard Group, Inc. discloses a 5.34% stake in Centamin plc as of 14 November 2024. Additional disclosure related to AngloGold Ashanti plc The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Centamin Plc AngloGold Ashanti Plc
BRIEF published on 11/15/2024 at 15:12, 7 days 11 hours ago The Vanguard Group Discloses 4.91% Stake in Smith (DS) plc The Vanguard Group Takeover Code Stake Disclosure Smith (DS) Plc Securities Position
PRESS RELEASE published on 11/15/2024 at 15:11, 7 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses 4.07% ownership in AngloGold Ashanti plc. They made purchases of USD 1 ordinary shares The Vanguard Group Stock Purchase Ownership Disclosure Financial Disclosure AngloGold Ashanti Plc
BRIEF published on 11/15/2024 at 15:10, 7 days 12 hours ago The Vanguard Group Discloses Position in Spirent Communications plc Takeover Code Securities Disclosure Vanguard Group Spirent Communications Share Dealing
PRESS RELEASE published on 11/15/2024 at 15:07, 7 days 12 hours ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.91% stake in Smith (DS) plc. Latest position disclosed on 14 Nov 2024 in accordance with Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group Stake Disclosure Smith (DS) Plc
PRESS RELEASE published on 11/15/2024 at 15:05, 7 days 12 hours ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses a 5.21% stake in Spirent Communications plc in a Form 8.3 submission as of 14 November 2024 Form 8.3 Vanguard Group Stake Disclosure Financial Holdings Spirent Communications
Published on 11/22/2024 at 23:55, 3 hours 16 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 3 hours 41 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 4 hours 6 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 4 hours 41 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 8 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 9 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 10 hours 15 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 11 hours 10 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 20 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 7 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
